Study to Evaluate Efficacy and Safety of Imiglucerase Treatment in Chinese Patients With Gaucher Disease Type Ⅲ

Clinical trial NCT04656600 · COMPLETED

Trial details

NCT number: NCT04656600
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Gaucher's Disease

Start date: 2021-03-02
Primary completion: 2023-10-12
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.